| Analysis | Metabolite Name | Measured Value | Units | Treatment |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | pyruvate | 32226.59 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | pyruvate | 50351.06 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | pyruvate | 54644.31 | Peak area (top) | DMSO |
| Reversed phase NEGATIVE ION MODE | pyruvate | 56501.71 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | pyruvate | 62624.52 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | pyruvate | 62774.99 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | pyruvate | 63011.23 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | pyruvate | 65940.78 | Peak area (top) | ML210 |
| Reversed phase NEGATIVE ION MODE | pyruvate | 68475.44 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | pyruvate | 69164.64 | Peak area (top) | RSL3 |
| Reversed phase NEGATIVE ION MODE | pyruvate | 78141.8 | Peak area (top) | ML162 |
| Reversed phase NEGATIVE ION MODE | pyruvate | 93021.34 | Peak area (top) | ML162 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|